Anti-infliximab antibodies developed in patients treated for severe hidradenitis suppurativa

被引：0
|
作者：
Peeters, M. -A. [1 ]
Laffitte, E. [1 ]
机构：
[1] Univ Geneva, Dermatol, Geneva, Switzerland
来源：
EXPERIMENTAL DERMATOLOGY | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P16
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [31] Infliximab (Remicade): A new treatment alternative for severe hidradenitis suppurativa?
    Thielen, Anne-Marie
    Barde, Caroline
    Saurat, Jean-Hilaire
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (07) : 1813 - 1813
  • [32] The clinical and immunological significance of low level of infliximab in the absence of anti-infliximab antibodies in patients with IBD
    Ungar, B.
    Anafy, A.
    Yavzori, M.
    Picard, O.
    Fudim, E.
    Kopylov, U.
    Ron, Y.
    Yanai, H.
    Dotan, I.
    Chowers, Y.
    Eliakim, R.
    Ben-Horin, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S113 - S113
  • [33] Tolerance and safety of infliximab in the treatment of moderate to severe Hidradenitis Suppurativa
    Marechal, Antonin
    Glanard, Audrey
    Maruani, Annabel
    Pourrat, Xavier
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 189 - 190
  • [34] Treatment of severe hidradenitis suppurativa with infliximab in combination with surgical interventions
    van Rappard, D. C.
    Mekkes, J. R.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (01) : 206 - 208
  • [35] Four-weekly infliximab in the treatment of severe hidradenitis suppurativa
    Moriarty, B.
    Jiyad, Z.
    Creamer, D.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (04) : 986 - 987
  • [36] Severe hidradenitis suppurativa successfully treated with secukinumab
    Glowaczewska, Amelia
    Szepietowski, Jacek C.
    Matusiak, Lukasz
    [J]. DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [37] Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD - authors' reply
    Ben-Horin, S.
    Chowers, Y.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (05) : 501 - 501
  • [38] The Clinical and Immunological Significance of Low Level of Infliximab in the Absence of Anti-Infliximab Antibodies in Patients With IBD
    Ungar, Bella
    Anafy, Adi
    Kopylov, Uri
    Ron, Yulia
    Yanai, Henit
    Dotan, Iris
    Chowers, Yehuda
    Eliakim, Abraham R.
    Ben-Horin, Shomron
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S245 - S245
  • [39] Serum trough infliximab and anti-infliximab antibodies in a cohort of gastroenterology and rheumatology patients' infliximab therapeutic drug monitoring
    Barlow, Nicola L.
    Mohammed, Pervaz
    Berg, Jonathan D.
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2016, 53 (04) : 477 - 484
  • [40] Infliximab for hidradenitis suppurativa: report of seven consecutive patients
    Dupuy, A
    Fardet, L
    Kerob, D
    Levy, A
    Bachelez, H
    Morel, P
    Lebbe, C
    [J]. EXPERIMENTAL DERMATOLOGY, 2006, 15 (06) : 482 - 482
12345